This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ryan, C. Articles by Sullivan, S. J. Search for Related Content PubMed PubMed Citation Articles by Ryan, C. Articles by Sullivan, S. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 07 1995, 1720-1726, Vol 33, No. 7
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Rapid assay for mycobacterial growth and antibiotic susceptibility using gel microdrop encapsulation

C Ryan, BT Nguyen and SJ Sullivan
One Cell Systems, Inc., Cambridge, Massachusetts 02139, USA.

Effective control of tuberculosis transmission in vulnerable population groups is dependent on rapid identification of the infectious agent and its drug susceptibility. However, the slow growth rate of mycobacteria has undermined the ability to quickly identify antimicrobial resistance. These studies describe a mycobacterial growth assay based on microencapsulation technology used in conjunction with flow cytometric analysis. Mycobacteria were encapsulated in agarose gel microdrops approximately 25 microns in diameter, and colony growth was monitored by using flow cytometry to evaluate the intensity of auramine staining after culture for various times at 37 degrees C. By this method, colony growth of Mycobacterium bovis and M. smegmatis could be quantified within 1 to 3 days after encapsulation. Inhibition of growth by rifampin and isoniazid was also evaluated in this time period, and the presence of an isoniazid-resistant subpopulation representing 3% of the total microorganisms could be detected. This use of encapsulation and flow cytometry has the potential to facilitate rapid and automated evaluation of inhibition of growth by antimicrobial agents and shorten the time frame for analysis of clinical specimens.

This article has been cited by other articles:

• Dang, S. M., Gerecht-Nir, S., Chen, J., Itskovitz-Eldor, J., Zandstra, P. W. (2004). Controlled, Scalable Embryonic Stem Cell Differentiation Culture. Stem Cells 22: 275-282 [Abstract] [Full Text]  
• Zengler, K., Toledo, G., Rappe, M., Elkins, J., Mathur, E. J., Short, J. M., Keller, M. (2002). Cultivating the uncultured. Proc. Natl. Acad. Sci. USA 99: 15681-15686 [Abstract] [Full Text]  
• Alvarez-Barrientos, A., Arroyo, J., Canton, R., Nombela, C., Sanchez-Perez, M. (2000). Applications of Flow Cytometry to Clinical Microbiology. Clin. Microbiol. Rev. 13: 167-195 [Abstract] [Full Text]  
• Eltringham, I. J., Wilson, S. M., Drobniewski, F. A. (1999). Evaluation of a Bacteriophage-Based Assay (Phage Amplified Biologically Assay) as a Rapid Screen for Resistance to Isoniazid, Ethambutol, Streptomycin, Pyrazinamide, and Ciprofloxacin among Clinical Isolates of Mycobacterium tuberculosis. J. Clin. Microbiol. 37: 3528-3532 [Abstract] [Full Text]